Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brachytherapy sources

This article was originally published in The Gray Sheet

Executive Summary

FDA guidance issued Aug. 2 recognizes five standards for use in abbreviated 510(k) applications. Cardiovascular brachytherapy devices for prevention of restenosis are not addressed by the document. While the guidance is appropriate for sponsors seeking general claims for photon-emitting brachytherapy sources, specific claims should be handled using the agency's "Guidance for Industry on General/Specific Intended Use"
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT013778

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel